Bitdeer Technologies Holding Co - Ordinary Shares 10-Q 18 Aug 21 2021 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	4 Months Ended
	Jun. 30, 2021	Aug. 18, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Entity Registrant Name	Blue Safari Group Acquisition Corp
Entity Incorporation, State or Country Code	D8
Entity File Number	001-40473
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	Cheung Kong Center,
Entity Address, Address Line Two	58 Floor, Unit 5801
Entity Address, Address Line Three	2 Queens Road Central
Entity Address, City or Town	Central
Entity Address, Country	HK
City Area Code	+852
Local Phone Number	9258 9728
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		6,100,000
Entity Central Index Key	0001853084
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false
Transition Report	true
Units, each consisting of one Class A ordinary share, with no par value, and one right to receive one-tenth of one Class A ordinary share
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, with no par value, and one right to receive one-tenth of one Class A ordinary share
Trading Symbol	BSGAU
Security Exchange Name	NASDAQ
Class A ordinary shares included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	BSGA
Security Exchange Name	NASDAQ
Rights included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Rights included as part of the units
Trading Symbol	BSGAR
Security Exchange Name	NASDAQ

UNAUDITED CONDENSED BALANCE SHE

UNAUDITED CONDENSED BALANCE SHEET	Jun. 30, 2021USD ($)
Assets:
Cash	$ 884,500
Prepaid Expenses	360,496
Deferred offering costs	0
Total current assets	1,244,996
Cash held in Trust Account	58,075,000
Total Assets	59,319,996
Liabilities and Shareholders' Equity
Accrued offering costs and expenses	174,102
Due to related party	271,930
Promissory note - related party	200,000
Total current liabilities	646,032
Deferred underwriters discount	2,012,500
Total liabilities	2,658,532
Commitments & Contingencies
Shareholders' Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	5,103,358
Accumulated deficit	(103,595)
Total shareholders' equity	5,000,005
Total Liabilities and Shareholders' Equity	59,319,996
Class A Ordinary Shares
Liabilities and Shareholders' Equity
Class A ordinary shares subject to possible redemption, 5,114,996 shares at redemption value	51,661,459
Shareholders' Equity:
Common stock	98
Total shareholders' equity	98
Class B Ordinary Shares
Shareholders' Equity:
Common stock	144
Total shareholders' equity	$ 144

UNAUDITED CONDENSED BALANCE S_2

UNAUDITED CONDENSED BALANCE SHEET (Parenthetical)	Jun. 30, 2021$ / sharesshares
Preferred stock, par value, (per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Temporary equity, shares outstanding	5,114,996
Class A Ordinary Shares
Common shares, par value | $ / shares	$ 0.0001
Common shares, shares authorized	100,000,000
Common shares, shares issued	985,004
Common shares, shares outstanding	985,004
Temporary equity, shares outstanding	5,114,996
Class A Common Stock Subject to Redemption
Temporary equity, shares outstanding	5,114,996
Class B Ordinary Shares
Common shares, par value | $ / shares	$ 0.0001
Common shares, shares authorized	10,000,000
Common shares, shares issued	1,437,500
Common shares, shares outstanding	1,437,500

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	4 Months Ended
	Jun. 30, 2021	Jun. 30, 2021
Formation and operating costs	$ 95,585	$ 103,595
Loss from operations	(95,585)	(103,595)
Net loss	$ (95,585)	$ (103,593)
Ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding	957,843	5,127,279
Basic and diluted net income (loss) per share	$ 0	$ 0
Nonredeemable ordinary shares
Basic and diluted weighted average shares outstanding	1,619,217	1,566,689
Basic and diluted net income (loss) per share	$ (0.06)	$ (0.07)

UNAUDITED CONDENSED STATEMENT O

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY - USD ($)	Class B Ordinary Shares	Class A Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Feb. 22, 2021			$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					$ (8,010)
Balance at the end at Mar. 31, 2021			24,857	(8,010)	16,991
Balance at the beginning at Feb. 22, 2021			0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B ordinary share issued to initial shareholder	$ 144		24,857		25,001
Class B ordinary share issued to initial shareholder (in shares)	1,437,500
Net loss			0	(8,010)	(103,593)
Balance at the end at Jun. 30, 2021	$ 144	$ 98	5,103,358	(103,595)	5,000,005
Balance at the end (in shares) at Jun. 30, 2021	1,437,500	985,004
Balance at the beginning at Mar. 31, 2021			24,857	(8,010)	16,991
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of 292,500 Private Placement Units on June 14, 2021		$ 29	2,924,971	0	2,925,000
Sale of 292,500 Private Placement Units on June 14, 2021 (in shares)		292,500
Sale of 5,000,000 Units on June 14, 2021 through public offering		$ 500	49,999,500	0	50,000,000
Sale of 5,000,000 Units on June 14, 2021 through public offering (in shares)		5,000,000
Sale of 750,000 Units on June 14, 2021 over-allotment		$ 75	7,499,925	0	7,500,000
Sale of 750,000 Units on June 14, 2021 over-allotment (in shares)		750,000
Issuance of representative shares		$ 6	569	0	575
Issuance of representative shares (in shares)		57,500
Class A ordinary shares subject to possible redemption (in shares)		(5,114,996)
Class A ordinary shares subject to possible redemption		$ (512)	(51,660,947)	0	(51,661,459)
Underwriters' discount			(1,150,000)	0	(1,150,000)
Other offering expenses			(523,017)	0	(523,017)
Net loss			0	(95,585)	(95,585)
Balance at the end at Jun. 30, 2021	$ 144	$ 98	5,103,358	(103,595)	5,000,005
Balance at the end (in shares) at Jun. 30, 2021	1,437,500	985,004
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Deferred underwriter Discount			$ (2,012,500)	$ 0	$ (2,012,500)

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY (Parenthetical) - shares	Jun. 14, 2021	Jun. 30, 2021
Sale of 5,000,000 Units on June 14, 2021 through public offering (in shares)	5,000,000
Stock Issued During Period, Shares, Issued for Services	750,000
Sale of Private Placement Warrants (in shares)	292,500
Over-allotment option
Sale of 5,000,000 Units on June 14, 2021 through public offering (in shares)	750,000	750,000
Initial Public Offering.
Sale of 5,000,000 Units on June 14, 2021 through public offering (in shares)	5,750,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS	4 Months Ended
	Jun. 30, 2021USD ($)
Cash flows from operating activities:
Net loss	$ (103,595)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by Sponsor	7,169
Changes in current assets and liabilities:
Accrued expenses	(260,570)
Prepaid Assets	(360,496)
Due to related party	271,930
Net cash used in operating activities	(445,562)
Cash flows from investing activities:
Principal deposited in Trust Account	(58,075,000)
Net cash used in investing activities	(58,075,000)
Cash flows from financing activities:
Proceeds from initial public offering	50,000,006
Proceeds from private placement	2,925,000
Proceeds from over allotment net of under writer discount	7,500,569
Payment of deferred offering costs	(1,020,513)
Net cash provided by financing activities	59,405,062
Net Change in Cash	884,500
Cash, beginning of the period	0
Cash, end of the period	884,500
Supplemental disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	25,001
Initial value of ordinary shares subject to possible redemption	51,661,459
Deferred underwriting commissions payable charged to additional paid in capital	2,012,500
Accrued deferred offering costs	$ 523,017

Organization and Business Opera

Organization and Business Operation	4 Months Ended
	Jun. 30, 2021
Organization and Business Operation
Organization and Business Operation	Note 1 — Organization and Business Operation Blue Safari Group Acquisition Corp. (the “Company”) is newly incorporated blank check company incorporated as a British Virgin Island (“BVI”) business company on February 23, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any potential Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any potential Business Combination target. As of June 30, 2021, the Company had not commenced any operations. All activity for the period from February 23, 2021 (inception) through June 30, 2021 relates to the Company’s formation and the Proposed Public Offering (the “IPO”) as defined below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The Company’s Sponsor is BSG First Euro Investment Corp., a British Virgin Islands company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on June 10, 2021 (the “Effective Date”). On June 14, 2021 the Company consummated the IPO of 5,750,000 units (the “Units”), including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $57,500,000, which is discussed in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of 292,500 units (the “Private Placement Unit”), at a price of $10.00 per Private Placement Unit, generating gross proceeds of $2,925,000, which is discussed in Note 4. Transaction costs of the IPO amounted to $3,685,517 consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $575 and $522,442 of other offering costs. Upon the closing of the IPO, an aggregate of $10.10 per Unit sold in the IPO, or an aggregate of $58,075,000, was held in a Trust Account (“Trust Account”) and will be invested only in U.S. government treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Proposed Public Offering and the private placement will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period (defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity and (iii) the redemption of all of the public shares if the Company is unable to complete the initial Business Combination within the Combination Period (defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the creditors, if any, which could have priority over the claims of the public shareholders. The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under the law or stock exchange listing requirement. The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have only 12 months from the closing of the IPO (the “Combination Period”) (or up to 18 months from the closing of the IPO if the Company extend the period of time to consummate a Business Combination by the full amount of time) to complete the initial Business Combination. If the Company has not completed the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor, officers and directors have agreed to (i) to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the trust account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company submits the initial Business Combination to the public shareholders for a vote, the insiders have agreed, pursuant to such letter agreement, to vote their founder shares, private placement shares and any public shares purchased during or after the IPO in favor of the initial Business Combination. The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third -party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy their indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. The Company has not asked the Sponsor to reserve for such obligations. Liquidity and Management’s Plan As of June 30, 2021, the Company had $884,500 in cash, and working capital of $598,964 (not taken into account tax obligations). The Company’s liquidity needs prior to the consummation of the IPO were satisfied through the proceeds of $25,001 from the sale of the Founders Shares (as defined in Note 5), and loan proceeds from the Sponsor of $200,000 under the Note (Note 5). Subsequent from the consummation of the IPO, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the IPO and the Private Placement held outside of the Trust Account. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	4 Months Ended
	Jun. 30, 2021
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statement in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021. Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to shareholders’ equity upon the completion of the IPO. Accordingly, as of June 30, 2021, offering costs in the aggregate of $3,685,517 have been charged to shareholders’ equity (consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $575 and $522,442 of other offering costs. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement . Cash Held in Trust Account At June 30, 2021, the Company had $58,075,000 in cash held in the Trust Account. Due to Related Party The balance of $271,930 is represented by $7,333 accrued for the administrative support services provided by the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market, and $264,597 of accrued expenses paid by the Sponsor on behalf of the Company. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021, 5,114,996 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

Initial Public Offering

Initial Public Offering	4 Months Ended
	Jun. 30, 2021
Initial Public Offering
Initial Public Offering	Note 3 — Initial Public Offering On June 14, 2021, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment. Each Unit consists of one ordinary share (“Ordinary Share”) and one right (“Right”) to receive one-tenth

Private Placement

Private Placement	4 Months Ended
	Jun. 30, 2021
Private Placement
Private Placement	Note 4 — Private Placement Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 292,500 Units (“Private Placement Units”), which included the additional 22,500 Private Placement Units sold pursuant to the full exercise of the underwriters’ option to cover the over-allotment. The Private Placement Units and their component securities will not be transferable, assignable or salable until 30 days after the consummation of the initial Business Combination except to permitted transferees, and they will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

Related Party Transactions

Related Party Transactions	4 Months Ended
	Jun. 30, 2021
Related Party Transactions
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On February 23, 2021 and March 4, 2021, the Company’s Sponsor paid $25,001, or approximately $0.017 per share, to cover certain of the offering and formation costs in exchange for an aggregate of 1,437,500 Class B ordinary shares (“Founder shares’), par value $0.0001 per share, 187,500 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. On June 14, 2021, the underwriter exercised the over-allotment option in full, hence, the 187,500 Founder Shares that are no longer subject to forfeiture. The Company’s initial shareholders have agreed not to transfer, assign or sell any of its founder shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination or (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property (except as described herein under “Principal Shareholders — Transfers of Founder Shares and Private Placement Units”). (the “Lock-up”). Promissory Note — Related Party On March 1, 2021, the Company issued the Promissory Note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $200,000. The Promissory Note is non-interest bearing and payable promptly after the date on which the Maker consummates the IPO of its securities. As of June 30, 2021, the Company had borrowed $200,000 under the promissory note. Working Capital Loans In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,150,000 of the Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. As of June 30, 2021, no such Working Capital Loans were outstanding.

Commitments and Contingencies

Commitments and Contingencies	4 Months Ended
	Jun. 30, 2021
Commitments and Contingencies
Commitments and Contingencies	Note 6 — Commitments & Contingencies Registration Rights The holders of the founder shares, Private Placement Units, shares being issued to the underwriters of the Proposed Public Offering, and units that may be issued on conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Public Offering requiring the Company to register such securities for resale (in the case of the founder shares, only after conversion to the Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Underwriting Agreement The underwriters have a 45-day option from June 14, 2021 to purchase up to an additional 750,000 Units, consisting of 750,000 Class A ordinary shares and 750,000 rights to cover over-allotments, if any. On June 14, 2021, the underwriter fully exercised the over-allotment option to purchase 750,000 Units, and paid an underwriting commission in aggregate of $1,150,000. Additionally, the underwriters will be entitled to a deferred underwriting commissions of 3.5% of the gross proceeds of the IPO held in the Trust Account, or $2,012,500 upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement. Representative’s Ordinary Shares The Company issued to Maxim Partners LLC and/or its designees, 57,500 shares upon the consummation of the IPO. Maxim has agreed not to transfer, assign or sell any such shares until the completion of our initial business combination. In addition, Maxim has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete our initial business combination within 12 months from the closing of the IPO, or up to 18 months from the closing of the IPO if the Company extends the period of time to consummate a business combination. The shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule 5110(e)(1). Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates. Right of First Refusal For a period beginning on the closing of the IPO and ending 12 months from the closing of a business combination, the Company has granted Maxim a right of first refusal to act as lead-left book running manager and lead left placement agent for any and all future private or public equity, equity-linked, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three years from the commencement of sales in the IPO.

Shareholders Equity

Shareholders Equity	4 Months Ended
	Jun. 30, 2021
Shareholder's Equity
Shareholder's Equity	Note 7 — Shareholders’ Equity Preference Shares — outstanding Class A Ordinary Shares Class B Ordinary Shares— outstanding

Subsequent Events

Subsequent Events	4 Months Ended
	Jun. 30, 2021
Subsequent Events
Subsequent Events	Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statement was issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statement.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	4 Months Ended
	Jun. 30, 2021
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of financial statement in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021.
Offering Costs Associated with IPO	Offering Costs Associated with IPO The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to shareholders’ equity upon the completion of the IPO. Accordingly, as of June 30, 2021, offering costs in the aggregate of $3,685,517 have been charged to shareholders’ equity (consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $575 and $522,442 of other offering costs.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement .
Cash Held in Trust Account	Cash Held in Trust Account At June 30, 2021, the Company had $58,075,000 in cash held in the Trust Account.
Due to Related Party	Due to Related Party The balance of $271,930 is represented by $7,333 accrued for the administrative support services provided by the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market, and $264,597 of accrued expenses paid by the Sponsor on behalf of the Company.
Class A Common Stock Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares is classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at June 30, 2021, 5,114,996 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Concentration of Credit Risk	Concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

Organization and Business Ope_2

Organization and Business Operation (Details)	Jun. 30, 2021USD ($)$ / sharesshares	Jun. 14, 2021USD ($)$ / sharesshares	Jun. 30, 2021USD ($)$ / sharesshares	Jun. 30, 2021USD ($)item$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination, minimum number of businesses | item				1
Obligation to redeem Public Shares if entity does not complete a business combination (as a percent)				100.00%
Redemption of shares calculated based on business days prior to consummation of business combination (in days)				2 days
Investment of cash in Trust Account, per unit | $ / shares	$ 10.10		$ 10.10	$ 10.10
Increase in investment of cash in trust account, per unit | $ / shares	$ 0.20		$ 0.20	$ 0.20
Condition for future business combination threshold net tangible assets	$ 5,000,001		$ 5,000,001	$ 5,000,001
Threshold period to complete business combination				12 months
Threshold period To complete business combination, if elected to extend business consumption period				18 months
Threshold business days for redemption of public shares				10 days
Maximum allowed dissolution expenses				$ 50,000
Number of units issued | shares		5,000,000
Cash equivalents	884,500		884,500	884,500
Underwriting discount	1,150,000		(1,150,000)
Fair value of the representative shares	575		575	575
Other offering costs	522,442		(523,017)
Working capital deficit				598,964
Aggregate purchase price				25,001
Proceeds from issuance initial public offering				50,000,006
Payments for investment of cash in Trust Account				(58,075,000)
Proceeds from sale of warrants | shares		292,500
Deferred underwriters discount	2,012,500		2,012,500	2,012,500
Cash held in Trust Account	$ 58,075,000		$ 58,075,000	$ 58,075,000
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of units		$ 57,500,000
Purchase price, per unit | $ / shares		$ 10
Number of shares in a unit | shares		1
Number of rights in a unit | shares		1
Number of shares in a right | shares		0.1
Investment of cash in Trust Account, per unit | $ / shares	$ 10.10		$ 10.10	$ 10.10
Number of units issued | shares		5,750,000
Gross proceeds from units issued		$ 57,500,000
Underwriting discount				$ 1,150,000
Fair value of the representative shares	$ 575		$ 575	575
Other offering costs				522,442
Unit price | $ / shares		$ 10
Deferred underwriters discount	2,012,500		2,012,500	2,012,500
Transaction costs				3,685,517
Cash held in Trust Account	$ 58,075,000		$ 58,075,000	58,075,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares		292,500
Proceeds from sale of Private Placement Warrants				$ 2,925,000
Exercise price of warrants | $ / shares	$ 10		$ 10	$ 10
Proceeds from sale of warrants | shares	292,500		292,500	292,500
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares		750,000		750,000
Class A Ordinary Shares
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares			5,000,000
Sponsor
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price				$ 25,001
Proceeds from unsecured promissory note				$ 200,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2021	Jun. 14, 2021	Mar. 04, 2021	Feb. 23, 2021
Unrecognized tax benefits	$ 0	$ 0	$ 0
Unrecognized tax benefits accrued for interest and penalties	0	0	0
Deferred underwriters discount	$ 2,012,500	$ 2,012,500	$ 2,012,500
Class A common stock subject to possible redemption, outstanding (in shares)	5,114,996	5,114,996	5,114,996
Proceeds from issuance of private placement			$ 2,925,000
Offering costs	$ 3,685,517
Cash held in Trust Account	58,075,000	$ 58,075,000	58,075,000
Due to related party	271,930	271,930	271,930
Underwriting discount	1,150,000	(1,150,000)
Other offering costs	522,442	(523,017)
Deferred underwriting discount	2,012,500	2,012,500	2,012,500
Federal depository insurance coverage amount	250,000	250,000	250,000
Fair value of the representative shares	575	575	575
Cash equivalent	0	0	0
Sponsor
Accrued expense	7,333	7,333	7,333
Accrued expense paid			264,597
Initial Public Offering.
Deferred underwriters discount	2,012,500	2,012,500	2,012,500
Cash held in Trust Account	58,075,000	58,075,000	58,075,000
Transaction costs			3,685,517
Underwriting discount			1,150,000
Other offering costs			522,442
Fair value of the representative shares	$ 575	$ 575	$ 575
Class A Ordinary Shares
Class A common stock subject to possible redemption, outstanding (in shares)	5,114,996	5,114,996	5,114,996
Class B Ordinary Shares | Sponsor
Shares subject to forfeiture				187,500	187,500	187,500

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Jun. 14, 2021	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Number of units issued	5,000,000
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Number of units issued	5,750,000
Number of shares in a unit	1
Number of rights in a unit	1
Number of shares in a right	0.1
Purchase price, per unit	$ 10
Gross proceeds from units issued	$ 57,500,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	750,000	750,000

Private Placement (Details)

Private Placement (Details) - USD ($)	Jun. 14, 2021	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Number of units issued	5,000,000
Proceeds from sale of warrants	292,500
Private Placement.
Subsidiary, Sale of Stock [Line Items]
Number of units issued	292,500
Threshold period for not to transfer, assign or sell any of their shares or units after the completion of the initial business combination		30 days
Aggregate purchase price		$ 2,925,000
Proceeds from sale of warrants		292,500
Private Placement, Over-Allotment Option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	22,500

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - USD ($)	Jun. 14, 2021	Mar. 04, 2021	Feb. 23, 2021	Jun. 30, 2021
Related Party Transaction [Line Items]
Aggregate purchase price				$ 25,001
Number of units issued	5,000,000
Initial Public Offering.
Related Party Transaction [Line Items]
Purchase price, per unit	$ 10
Number of units issued	5,750,000
Over-allotment option
Related Party Transaction [Line Items]
Number of units issued	750,000			750,000
Class B Ordinary Shares
Related Party Transaction [Line Items]
Aggregate purchase price				$ 144
Number of shares issued				1,437,500
Common shares, par value				$ 0.0001
Sponsor
Related Party Transaction [Line Items]
Aggregate purchase price				$ 25,001
Restrictions on transfer period of time after business combination completion				6 months
Sponsor | Class B Ordinary Shares
Related Party Transaction [Line Items]
Aggregate purchase price		$ 25,001	$ 25,001
Purchase price, per unit		$ 0.017	$ 0.017
Number of shares issued		1,437,500	1,437,500
Common shares, par value		$ 0.0001	$ 0.0001
Shares subject to forfeiture	187,500	187,500	187,500

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Jun. 30, 2021	Mar. 01, 2021
Working capital loans warrant
Related Party Transaction [Line Items]
Outstanding balance of related party note	$ 0
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note		$ 200,000
Outstanding balance of related party note	200,000
Related Party Loans
Related Party Transaction [Line Items]
Loan conversion agreement warrant	$ 1,150,000
Related Party Loans | Working capital loans warrant
Related Party Transaction [Line Items]
Price of warrant	$ 10

Commitments and Contingencies (

Commitments and Contingencies (Details)	Jun. 14, 2021shares	Jun. 30, 2021USD ($)itemshares
Loss Contingencies [Line Items]
Maximum number of demands for registration of securities | item		3
Number of units issued	5,000,000
Aggregate underwriter cash discount, including over-allotment | $		$ 1,150,000
Deferred underwriting discount, percent		3.50%
Threshold period to complete business combination		12 months
Threshold period To complete business combination, if elected to extend business consumption period		18 months
Over-allotment option
Loss Contingencies [Line Items]
Underwriters option to purchase, term		45 days
Number of units issued	750,000	750,000
Total shares issuable for units		750,000
Total rights issuable for units		750,000
Maxim Partners LLC and/or its designees
Loss Contingencies [Line Items]
Number of shares agreed to purchase, including over-allotment		57,500
Threshold period of right of first refusal from business combination closure		12 months

Shareholders Equity - Preferred

Shareholders Equity - Preferred Stock Shares (Details)	Jun. 30, 2021$ / sharesshares
Shareholder's Equity
Preferred shares, shares authorized	1,000,000
Preferred stock, par value, (per share) | $ / shares	$ 0.0001
Preferred shares, shares issued	0
Preferred shares, shares outstanding	0

Shareholders Equity - Common St

Shareholders Equity - Common Stock Shares (Details) - USD ($)	Jun. 14, 2021	Mar. 04, 2021	Feb. 23, 2021	Jun. 30, 2021	Mar. 31, 2021
Class of Stock [Line Items]
Aggregate purchase price				$ 25,001
Number of units issued	5,000,000
Class A common stock subject to possible redemption, outstanding (in shares)				5,114,996
Sponsor
Class of Stock [Line Items]
Aggregate purchase price				$ 25,001
Over-allotment option
Class of Stock [Line Items]
Number of units issued	750,000			750,000
Initial Public Offering.
Class of Stock [Line Items]
Purchase price, per unit	$ 10
Number of units issued	5,750,000
Class B Ordinary Shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)				10,000,000
Common shares, par value (in dollars per share)				$ 0.0001
Common shares, shares issued (in shares)				1,437,500	1,437,500
Common Stock, Shares, Outstanding				1,437,500
Aggregate purchase price				$ 144
Class B Ordinary Shares | Sponsor
Class of Stock [Line Items]
Common shares, par value (in dollars per share)		$ 0.0001	$ 0.0001
Common shares, shares issued (in shares)				1,437,500
Common Stock, Shares, Outstanding				1,437,500
Aggregate purchase price		$ 25,001	$ 25,001
Purchase price, per unit		$ 0.017	$ 0.017